Rocket


News + Filings
Transactions



Combs Andrew

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
02/07/2023Prelude Therapeutics IncPRLDGrantEmployee Stock Option (right to buy)135k$7.20$972k 02/07/2023
04/01/2022Prelude Therapeutics IncPRLDExerciseEmployee Stock Option (right to buy)36.1k$1.89$68.2k 03/31/2022
03/31/2022Prelude Therapeutics IncPRLDExerciseCommon Stock36.1k$1.89$68.2k 03/31/2022
02/15/2022Prelude Therapeutics IncPRLDGrantEmployee Stock Option (right to buy)100k$10.58$1.1M 02/15/2022
12/14/2021Prelude Therapeutics IncPRLDPurchaseCommon Stock4k$11.60$46.4k 12/13/2021
12/13/2021Prelude Therapeutics IncPRLDPurchaseCommon Stock4k$12.12$48.5k 12/13/2021
07/20/2021Prelude Therapeutics IncPRLDGrantEmployee Stock Option (Right to Buy)95k$31.23$3M 07/20/2021
09/29/2020Prelude Therapeutics IncPRLDPurchaseCommon Stock1000$19.00$19k 09/29/2020

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy